|Event Name||CHI's 2016 2nd Annual Reproductive Genetic Diagnostics Conference
Thursday, December 01, 2016
Friday, December 02, 2016
Boston Marriott Cambridge
|Cost||$679 - $2,749
|Description||Couples experiencing infertility or failed pregnancy can now take advantage of a number of molecular diagnostic options to determine the health and wellness of their embryos as well as their own fertility. Cambridge Healthtech Institute’s Second Annual Reproductive Genetic Diagnostics conference examines the latest in preimplantation diagnostic and screening technologies, including their applications in assessing mosaicism, determining embryo transfer, and evolution in CCS. The meeting will also examine the potential for less- and non-invasive PGD, being developed in response to the potential effect biopsy and vitrification may have on the development of the embryo. There will be discussion on PGD for donor eggs, such as how much or how often testing should be done. The meeting will also cover advances in CRISPR, including current research and capabilities, as well as how this technology may or may not be used in the future. New this year, special attention will be paid to molecular diagnostics for finding infertility biomarkers.